Saracatinib, a Src Tyrosine Kinase Inhibitor, as a Disease Modifier in the Rat DFP Model: Sex Differences, Neurobehavior, Gliosis, Neurodegeneration, and Nitro-Oxidative Stress is a research paper published in Antioxidants (2021). On theSindex it has a DataRank of 0. It has been cited 27 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: NS110648
NINDS NIH HHS
Grant: R21 NS110648
National Institutes of Health
Grant: 1R21NS110648-01
Saracatinib Mitigates OP nerve agent-induced Long-term Neurotoxicity
FWCI
1.95
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals